ギラン・バレー症候群:グローバル臨床試験動向(2014年上半期)...市場調査レポートについてご紹介

【英文タイトル】Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Guillain-Barre Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Guillain-Barre Syndrome to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Guillain-Barre Syndrome to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Guillain-Barre Syndrome 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Guillain-Barre Syndrome Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Harvard Pilgrim Health Care, Inc. 31
Clinical Trial Overview of Harvard Pilgrim Health Care, Inc. 31
GlaxoSmithKline plc 32
Clinical Trial Overview of GlaxoSmithKline plc 32
CSL Limited 33
Clinical Trial Overview of CSL Limited 33
Clinical Trial Overview of Top Institutes / Government 34
Erasmus MC 34
Clinical Trial Overview of Erasmus MC 34
FDA Office of Orphan Products Development 35
Clinical Trial Overview of FDA Office of Orphan Products Development 35
Chhatrapati Shahuji Maharaj Medical University 36
Clinical Trial Overview of Chhatrapati Shahuji Maharaj Medical University 36
Mansoura University 37
Clinical Trial Overview of Mansoura University 37
University Medical Centre Ljubljana 38
Clinical Trial Overview of University Medical Centre Ljubljana 38
University of Versailles 39
Clinical Trial Overview of University of Versailles 39
University of Cologne 40
Clinical Trial Overview of University of Cologne 40
NHS Greater Glasgow and Clyde 41
Clinical Trial Overview of NHS Greater Glasgow and Clyde 41
National Taiwan University Hospital 42
Clinical Trial Overview of National Taiwan University Hospital 42
Five Key Clinical Profiles 43
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 71
About GlobalData 72
Contact Us 72
Disclaimer 72
Source 72


【レポート販売概要】

■ タイトル:ギラン・バレー症候群:グローバル臨床試験動向(2014年上半期)
■ 英文:Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2014
■ 発行日:2014年6月30日
■ 調査会社:GlobalData
■ 商品コード:GDHC2221CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。